Assiene Oyong Damase Serge, Tamdjo Ange Hillary, Minoué Kuum Marc Germain, Youego Kouam Laetitia Elise, Cedric Gueguim, William Djeukeu Asongni, Assiene Agamou Julien Armel & Dieudonné Adiogo·Microbiology Research Journal International·2026
Aims: The study aims to assess the seroprevalence of anti-SARS-CoV-2 IgM and IgG antibodies among ambulatory patients in Yaoundé and to identify clinical and demographic correlates associated with the humoral immune response. Methods: An analytical cross-sectional study was condu...
Open access
Research Article10.9734/mrji/2026/v36i71763
Coronavirus, a member of the beta coronavirus family, encompasses a range of illnesses from common colds to severe disorders. SARS-CoV-2, transmitted mainly through respiratory droplets that are generated by a patient who is sneezing, coughing and talking, caused the global pande...
Open access
Research Article10.9734/mrji/2025/v35i11532
Background: The pandemic illness of coronavirus 2019 is caused by (SARS-CoV-2), it was started from China in December 2019. It speedily disseminate in the world and became a general threat. More than 5 million persons have died in the world. Aim of the Study: For assessments the...
Open access
Research Article10.9734/mrji/2023/v33i11-121412
COVID-19 is a global health problem responsible for significant morbidity and mortality and a major socioeconomic impact. While the major manifestation is respirator with a risk of acute respiratory distress syndrome, several extrapulmonary aspects, particularly cardiovascular, h...
Open access
Research Article10.9734/ajmah/2023/v21i9861
In December 2019, a mysterious pneumonia case was first reported in Wuhan, Hubei Province known as COVID-19, and its etiologic agent, SARS-Cov-2 virus. C-Reactive Protein (CRP) is a homopentameric protein that appears in inflammatory conditions. Erythrocyte sedimentation rate (ES...
Open access
Research Article10.9734/ajmah/2023/v21i7844
Md. Zillur Rahman, Nazmun Nahar, Rawshan Akhtar, Md. Mahbubul Alam, Shamsul Alom Swapon, Rubaiyat Rashid & Abdul Hamid Mollah·Asian Journal of Medicine and Health·2023
Background: An outbreak of Covid-19 caused by the SARS-Cov-2 initially emerged in China in December 2019 and the first Covid-19 patient was detected on 8 March 2020 in Bangladesh. The preconception about the major symptoms and outcomes of Covid-19-positive patients may be helpful...
Open access
Research Article10.9734/ajmah/2023/v21i6817
There are no effective treatments for COVID-19 caused by SARS-CoV-2 viruses worldwide and the effects of vaccines on new genetic variants of the virus are still uncertain. Therefore, initial diagnosis and management are essential for controlling the pandemic. The conventional dia...
Open access
Research Article10.9734/ajmah/2022/v20i1030518
As the nasal mucosa is generally the first site of infection, intranasal vaccinations have a distinct advantage over conventional COVID-19 vaccines. According to preclinical and clinical investigations, intranasal vaccination results in significant neutralizing antibody productio...
Open access
Research Article10.9734/ajmah/2022/v20i930492
A. D’Alessio, M. Cottini, C. Lombardi, M. Uccelli, F. Bracchi, G. Cesana, D. Di Mauro, A. Fargnoli, C. Giussani, F. Martini, M. Motta, S. Olmi, N. Sertori, M. Taverna & P. Del Poggio·Asian Journal of Medicine and Health·2021
Background: Hydroxychloroquine (HCQ) has been used against SARS-CoV-2, but large non randomized studies failed to show any clinical benefit. However, in these studies the drug was started in the hospital setting, a significant time after the onset of symptoms. Aim of the Study: t...
Open access
Research Article10.9734/ajmah/2021/v19i230301
Aim: To analyze spike proteins of Severe Acute Respiratory Syndrome (SARS)-related coronaviruses (CoVs) for their conserved motifs, Receptor-Binding Domain (RBD), Receptor Binding Motif (RBM) of SARS-CoV (CoV-1), SARS-CoV-2, Middle East Respiratory Syndrome (MERS)-CoV and their...
Open access
Research Article10.9734/mrji/2020/v30i830249
Violaine Guérin, Pierre Lévy, Jean-Louis Thomas, Thierry Lardenois, Philippe Lacrosse, Emmanuel Sarrazin, Natacha Regensberg-de Andreis & Martine Wonner·Asian Journal of Medicine and Health·2020
Aims: The challenge regarding COVID-19 is to prevent complications and fatal evolution. Azithromycin (AZM) and hydroxychloroquine (HCQ) have proven their antiviral effect in vitro. We aimed to assess the efficacy and safety of AZM alone or combined to HCQ, prescribed, at an early...
Open access
Research Article10.9734/ajmah/2020/v18i730224
Silas Lendzele Sevidzem, Aubin Armel Koumba, Christophe Roland Zinga- Koumba, Nonvignon Marius Kedote, Gaël Darren Maganga, Essé Elvire Agossou, Safiatou Niaré- Doumbo, Bitsha-Kitime Dieudoné Kabkia, Luc Salako Djogbenou, Genevieve Lydie Acapovi- Yao, Idrissa Sarr, Julien Zahouli Bi Zahouli, Chimène Nze- Nkoghé, Rodrigue Mintsa- Nguema, Athanase Badolo, Emmanuel Kamba Mebourou, Jacques François Mavoungou & Fatou Bintou Sarr·Asian Journal of Medicine and Health·2020
The world is experiencing an outbreak due to the new and mysterious SARS-CoV-2. Information regarding its source and transmission dynamics in different environments as well as medications for its prevention and cure is weak. This review seeks to document on the epidemiology, clin...
Open access
Research Article10.9734/ajmah/2020/v18i630213
Coronaviruses (CoV) are a large group from the Coronaviridae family that cause a variety of diseases, from the common cold to more serious clinical conditions such as SARS-CoV and MERS-CoV. This pathogen, which has a single chain, positive polarity and enveloped RNA viruses and c...
Open access
Research Article10.9734/ajmah/2020/v18i430194
Pneumonia triggered by novel coronavirus (SARS-CoV-2) in Wuhan, China in December 2019 is a extremely contagious disease. The WHO has stated the outbreak of Covid 19(Corona virus) as a pandemic issue. Currently, the research on this virus is in its primary stage. Based on the exi...
Open access
Research Article10.9734/ajmah/2020/v18i230185